This Day On The Street
Continue to site right-arrow
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
Stocks Under $10 with 50-100% upside potential - 14 days FREE!

Wednesday's Small-Cap Winners & Losers

Targacept (TRGT) surged on news that the biopharmaceutical firm will receive a $20 million milestone payment from AstraZeneca (AZN) in connection with the latter's decision to continue developing a proposed treatment for Alzheimer's and schizophrenia. Targacept shares were up $1.70, or 22.9%, to $9.14. AstraZeneca was adding 26 cents, or 0.5%, to $53.84.

PFSweb (PFSW) jumped after the Web-commerce company struck a deal with Fathead, an online purveyor of large vinyl wall stickers. Texas-based PFSweb will handle Fathead product orders, inventory, distribution, returns processing and customer service. Terms weren't specified. Shares were up 20 cents, or 18.7%, to $1.27.

Vascular Solutions (VASC) climbed on word regulators approved its D-Stat Flowable hemostat product for a new use. The Minneapolis-based company says that the product can now help prevent the formation of clinically significant hematomas in patients implanted with pulse generators, especially for those simultaneously treated with anticoagulants. D-Stat was previously approved for topical applications in 2002. Shares were trading up $1.19, or 15.8%, to $8.75.

Euro Tech Holdings (CLWT) plummeted after the Hong Kong-based company, which distributes water-treatment equipment, said it will take a 20% stake worth up to $4.5 million in Zhejiang Tianlan Desulfurization and Dust-Removal. Euro Tech predicts that demand for Zhejiang's services will increase as the Chinese government imposes restrictions on China's burgeoning sulfer dioxide emissions. Shares, however, were down 92 cents, or 19.1%, to $3.91.

Wolverine Tube (WLV) fell on news that it will be delisted by the New York Stock Exchange because it no longer meets minimum market capitalization requirements. The Huntsville, Ala.-based copper-products maker will now trade on the OTC Bulletin Board. Shares were losing 16 cents, or 12%, to $1.18.

Telik (TELK) dropped again following downgrades by three research firms. Analysts with Thomas Weisel, UBS and Needham & Co. all cut their ratings on the California-based pharmaceutical company. Prudential maintained an underweight rating on the stock. Telik plunged Tuesday after its proposed cancer drug, Telcyta, failed two late-stage studies. Shares were down 25 cents, or 5.2%, to $4.52.

Select the service that is right for you!

Action Alerts PLUS
Try it NOW

Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
  • Weekly roundups
TheStreet Quant Ratings
Try it NOW
Only $49.95/yr

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
  • Upgrade/downgrade alerts
Stocks Under $10
Try it NOW

David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
  • Weekly roundups
Dividend Stock Advisor
Try it NOW

Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Alerts when market news affect the portfolio
  • Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Real Money Pro
Try it NOW

All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

Product Features:
  • Real Money + Doug Kass Plus 15 more Wall Street Pros
  • Intraday commentary & news
  • Ultra-actionable trading ideas
Options Profits
Try it NOW

Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • 100+ monthly options trading ideas
  • Actionable options commentary & news
  • Real-time trading community
  • Options TV
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!


DOW 17,804.80 +26.65 0.15%
S&P 500 2,070.65 +9.42 0.46%
NASDAQ 4,765.38 +16.9840 0.36%

Brokerage Partners

Rates from

  • Mortgage
  • Credit Cards
  • Auto

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs